Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
53,311,882
-
Total 13F shares
-
17,587,930
-
Share change
-
+2,727,207
-
Total reported value
-
$215,095,371
-
Put/Call ratio
-
55%
-
Price per share
-
$12.23
-
Number of holders
-
123
-
Value change
-
+$34,918,930
-
Number of buys
-
73
-
Number of sells
-
34
Institutional Holders of Aktis Oncology, Inc. - Common Stock, $0.0001 par value per share (AKTSQ) as of Q4 2020
As of 31 Dec 2020,
Aktis Oncology, Inc. - Common Stock, $0.0001 par value per share (AKTSQ) was held by
123 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,587,930 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, Handelsbanken Fonder AB, Senvest Management, LLC, Portolan Capital Management, LLC, Herald Investment Management Ltd, NEEDHAM INVESTMENT MANAGEMENT LLC, Taylor Frigon Capital Management LLC, STATE STREET CORP, and UBS Group AG.
This page lists
123
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.